Chinese company announces investment in major European healthcare project

Linda Wong, CEO of China based Yihai Group, recently announced a 113 million USD initial investment in a European healthcare project that will provide both European and Chinese medicine and healthcare. The announcement was part of President Xi Jinping’s visit to the Czech Republic, and the investment will be part of President Jinping’s “One Belt, One Road” strategy. The strategy aims to improve Chinese trade and political relations with several regions, including Europe.

The healthcare project will be located in the Czech Republic, and will provide not only medical treatment, but also physical therapy and Tai Ji (tai chi). It will be based in Czech Františkovy Láznĕ (Emperor Francis II’s Village), which has previously hosted Beethoven, Karl Marx and other well-known historical figures.

Over the past 20 years, Yihai Group’s investments have included property developments in the US, private schools in China, and various projects within biotechnology and pharmaceuticals. The company’s recent focus on investing in healthcare and medicine is based on Ms. Wong’s personal views on making “a social contribution in her developments”.

Though not every Chinese investor shares Ms. Wong’s personal philosophy, many are seeing the value in investing in foreign healthcare opportunities. China’s healthcare sector is rapidly expanding to meet the needs of a massive population where increasing wealth is leading to a rise in “diseases of affluence”, including diabetes and hypertension. In order to support the development of their national healthcare sector, Chinese investors are sourcing innovation and knowledge from abroad by investing in foreign healthcare opportunities.

Naseba has established close ties with investors based in China. These investors are currently looking to invest in foreign healthcare opportunities within a variety of subsectors, including pharmaceuticals and medical technology.

On July 27th, 2016, Naseba will be hosting the Healthcare Investors Meeting in Beijing. At the meeting, pre-screened Chinese investors will be introduced to pre-qualified healthcare investment opportunities from around the world. To learn more, contact: